These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 15335398

  • 1. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
    Møller S, Henriksen JH.
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. New treatments of hepatorenal syndrome.
    Arroyo V, Terra C, Ginès P.
    Semin Liver Dis; 2006 Aug; 26(3):254-64. PubMed ID: 16850375
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.
    Arroyo V.
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402
    [Abstract] [Full Text] [Related]

  • 7. [Hepatorenal syndrome].
    Mijac D, Kezić A, Stojimirović B.
    Srp Arh Celok Lek; 2007 Sep; 135(1-2):98-104. PubMed ID: 17503577
    [Abstract] [Full Text] [Related]

  • 8. TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?
    Gülberg V, Gerbes AL.
    Z Gastroenterol; 2002 Sep; 40(9):823-6. PubMed ID: 12215953
    [Abstract] [Full Text] [Related]

  • 9. [Physiopathology of refractory ascites and the hepatorenal syndrome].
    Arroyo V.
    Nefrologia; 2002 Sep; 22 Suppl 5():41-6. PubMed ID: 12107916
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of hepatorenal syndrome.
    Kiser TH, Maclaren R, Fish DN.
    Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
    [Abstract] [Full Text] [Related]

  • 11. Therapy insight: Management of hepatorenal syndrome.
    Cárdenas A, Ginès P.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatorenal syndrome.
    Biswas KD, Jain AK.
    Trop Gastroenterol; 2002 Jun; 23(3):113-6. PubMed ID: 12693150
    [Abstract] [Full Text] [Related]

  • 14. Hepatorenal syndrome.
    Guevara M, Ginès P.
    Dig Dis; 2005 Jun; 23(1):47-55. PubMed ID: 15920325
    [Abstract] [Full Text] [Related]

  • 15. Terlipressin in hepatorenal syndrome: Evidence for present indications.
    Rajekar H, Chawla Y.
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
    [Abstract] [Full Text] [Related]

  • 16. Hepatorenal syndrome.
    Bataller R, Arroyo V, Ginès P, Sort P.
    Forum (Genova); 1998 Jan; 8(1):62-81. PubMed ID: 9565447
    [Abstract] [Full Text] [Related]

  • 17. The management of hepatorenal syndrome.
    Carl DE, Sanyal A.
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
    [Abstract] [Full Text] [Related]

  • 18. New challenge of hepatorenal syndrome: prevention and treatment.
    Wong F, Blendis L.
    Hepatology; 2001 Dec; 34(6):1242-51. PubMed ID: 11732014
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A, Landaverde C, Medici V, Rossaro L.
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.